SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
SCHEDULE
13D
[Rule
13d-101]
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO
§240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§240.13d-2(a)
(Amendment
No. 10 and Amendment No. 12)*
|
QUESTCOR
PHARMACEUTICALS INC.
|
|
(Name
of Issuer)
|
|
Common
Stock
|
|
(Title
of Class of Securities)
|
|
232808105
|
|
(CUSIP
Number)
|
|
Joseph
J. Giunta, Esq.
|
|
Skadden,
Arps, Slate, Meagher & Flom LLP
|
|
300
South Grand Avenue
|
|
Los
Angeles, CA 90071
|
|
(213)
687-5000
|
|
(Name,
Address and Telephone Number of Person Authorized to Receive Notices
and
Communications)
|
|
November
20, 2007
|
|
(Date
of Event Which Requires Filing of this Statement)
|
If
the filing person has previously
filed a statement on Schedule 13G to report the acquisition that is the subject
of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-(1)(g), check the following box £.
*The
remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover
page.
The
information required on the
remainder of this cover page shall not be deemed to be "filed" for the purpose
of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall be subject
to
all other provisions of the Act (however, see the
Notes).
| CUSIP No. 232808105 |
13D
|
Page 2
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Claudio
Cavazza
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Italy
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
1,756,781
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
4,701,445
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
IN
| CUSIP No. 232808105 |
13D
|
Page 3
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Paolo
Cavazza
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Italy
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
7,797,327
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
IN
| CUSIP No. 232808105 |
13D
|
Page 4
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Sigma-Tau
Finanziaria SpA
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Italy
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
0
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 5
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Sigma-Tau
International S.A.
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Luxembourg
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
0
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 6
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Defiante
Farmaceutica L.D.A.
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Portugal
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
0
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 7
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Aptafin
S.p.A.
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Italy
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
7,797,327
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 8
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Chaumiere
– Consultadoria & Servicos SDC Unipessoal LDA
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
WC
|
||||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Portugal
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
7,248,227
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 9
of 22
Pages
|
|
1
|
NAMES
OF REPORTING PERSONS
|
|||
|
Inverlochy
Consultadoria & Servicos L.D.A.
|
||||
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
S
|
||
|
(b)
£
|
||||
|
3
|
SEC
USE ONLY
|
|||
|
4
|
SOURCE
OF FUNDS
|
|||
|
|
||||
|
5
|
CHECK
IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
|
|||
|
PURSUANT
TO ITEM 2(d) OR 2(e)
|
£
|
|||
|
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|||
|
Portugal
|
||||
|
7
|
SOLE
VOTING POWER
|
|||
|
NUMBER
OF
|
0
|
|||
|
SHARES
|
||||
|
BENEFICIALLY
|
8
|
SHARED
VOTING POWER
|
||
|
OWNED
BY
|
14,255,553
|
|||
|
EACH
|
||||
|
REPORTING
|
9
|
SOLE
DISPOSITIVE POWER
|
||
|
PERSON
WITH
|
0
|
|||
|
10
|
SHARED
DISPOSITIVE POWER
|
|||
|
4,701,445
|
||||
|
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|||
|
14,255,553
|
||||
|
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
|
|||
|
CERTAIN
SHARES
|
£
|
|||
|
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|||
|
20.57%
|
||||
|
14
|
TYPE
OF REPORTING PERSON
|
|||
CO
| CUSIP No. 232808105 |
13D
|
Page 10
of 22
Pages
|
Amendment
No. 10 and
Amendment
No. 12 to
Statement
on Schedule 13D
This
Amendment No. 10 (the "Amendment No. 10") amends the Statement on Schedule
13D
filed with the Securities and Exchange Commission ("SEC") on March 25, 2002
(the
"Sigma/Defiante Schedule 13D"), as amended, relating to shares of the common
stock, no par value (the "Common Stock"), of Questcor Pharmaceuticals Inc.,
a
California corporation ("Questcor"). This Amendment No. 12 (the
"Amendment No. 12" and, together with the Amendment No. 10, this "Statement")
amends the Statement on Schedule 13D, filed with the SEC on August 7, 2001
(the
"Cavazza/Sigma Schedule 13D" and, together with the Sigma/Defiante Schedule
13D,
the "Schedule 13Ds"), as amended, relating to the shares of Common
Stock. Pursuant to Rule 13d-2 of Regulation 13D-G promulgated under
the Securities Exchange Act of 1934, as amended (the "Act"), this Amendment
No.
10 is being filed on behalf of Sigma-Tau Finanziaria SpA, an Italian corporation
("Sigma Tau") and Defiante Farmaceutica L.D.A., a Portuguese corporation
("Defiante") (formerly known as Defiante Farmaceutica Unipessoal L.D.A.), and
this Amendment No. 12 is being filed on behalf of Sigma-Tau International S.A.,
a Luxembourg corporation ("Sigma Tau International") (formerly known as
Sigma-Tau Finance Holding S.A.), Aptafin S.p.A., an Italian corporation
("Aptafin"), Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA, a
Portuguese corporation ("Chaumiere"), Inverlochy Consultadoria & Servicos
L.D.A., a Portuguese corporation ("Inverlochy"), Mr. Claudio Cavazza ("Mr.
C.
Cavazza") and Mr. Paolo Cavazza ("Mr. P. Cavazza" and, together with Mr. C.
Cavazza, Sigma Tau International, Aptafin, Chaumiere, Inverlochy, Defiante
and
Sigma Tau, the "Reporting Persons").
Item
3. Source and Amount of Funds or Other
Consideration.
Item
3 of the Schedule 13Ds are hereby amended to add the following:
On
November 20, 2007, Chaumiere used its working capital to purchase 2,446,782
shares of Common Stock from Mr. P. Cavazza at a purchase price of $4.68 per
share.
Item
5. Interest in Securities of the
Issuer.
Item
5 of the Schedule 13Ds are hereby amended as follows:
The
Reporting Persons, because they may be considered a "group" for purposes of
Section 13(d)(3) of the Act (the "Group"), may be deemed solely for purposes
of
U.S. securities laws to beneficially own (i) the 1,756,781 shares of Common
Stock directly owned by Mr. C. Cavazza, (ii) the 549,100 shares of Common Stock
directly owned by Aptafin, (iii) the 7,248,227 shares of Common Stock directly
owned by Chaumiere, and (iv) the 4,701,445 shares of Common Stock directly
owned
by Inverlochy. This represents beneficial ownership of an aggregate
of 14,255,553 shares of Common Stock. References to beneficial
ownership are made herein solely with respect to U.S. securities laws and are
not intended to refer or apply in any respect to any other issue under any
other
U.S. law.
(a) Percentage
interest calculations for the Reporting Persons are based upon Questcor having
69,296,099 shares of Common Stock outstanding as of November 1, 2007, as
reported by the Issuer in the Issuer’s Form 10-Q filed with the SEC on November
14, 2007.
Mr.
C. Cavazza
Pursuant
to Rule 13d-3 of the Act, Mr. C. Cavazza may be deemed to be the beneficial
owner of 14,255,553 shares of Common Stock, which constitutes approximately
20.57% of the Outstanding Shares.
Mr.
P. Cavazza
| CUSIP No. 232808105 |
13D
|
Page 11
of 22
Pages
|
Pursuant
to Rule 13d-3 of the Act, Mr. P. Cavazza may be deemed to be the beneficial
owner of 14,255,553 shares of Common Stock, which constitutes approximately
20.57% of the Outstanding Shares.
Sigma
Tau International
Pursuant
to Rule 13d-3 of the Act, Sigma Tau International may be deemed to be the
beneficial owner of 14,255,553 shares of Common Stock, which constitutes
approximately 20.57% of the Outstanding Shares.
Sigma
Tau
Pursuant
to Rule 13d-3 of the Act, Sigma Tau may be deemed to be the beneficial owner
of
14,255,553 shares of Common Stock, which constitutes approximately 20.57% of
the
Outstanding Shares.
Defiante
Pursuant
to Rule 13d-3 of the Act, Defiante may be deemed to be the beneficial owner
of
14,255,553 shares of Common Stock, which constitutes approximately 20.57% of
the
Outstanding Shares.
Aptafin
Pursuant
to Rule 13d-3 of the Act, Aptafin may be deemed to be the beneficial owner
of
14,255,553 shares of Common Stock, which constitutes approximately 20.57% of
the
Outstanding Shares.
Chaumiere
Pursuant
to Rule 13d-3 of the Act, Chaumiere may be deemed to be the beneficial owner
of
14,255,553 shares of Common Stock, which constitutes approximately 20.57% of
the
Outstanding Shares.
Inverlochy
Pursuant
to Rule 13d-3 of the Act, Inverlochy may be deemed to be the beneficial owner
of
14,255,553 shares of Common Stock, which constitutes approximately 20.57% of
the
Outstanding Shares.
Except
as set forth above, none of the Reporting Persons nor any of the persons listed
on Schedule A beneficially owns any other shares of Common Stock.
(b) Mr.
C. Cavazza
The
number of shares of Common Stock as to which Mr. C. Cavazza has the sole power
to vote or direct the vote is zero. The number of shares of Common
Stock as to which Mr. C. Cavazza shares the power to vote or direct the vote
is
14,255,553. The number of shares of Common Stock as to which Mr. C.
Cavazza has the sole power to dispose or direct the disposition is
1,756,781. The number of shares of Common Stock as to which Mr. C.
Cavazza shares the power to dispose or direct the disposition is
4,701,445.
Mr.
P. Cavazza
The
number of shares of Common Stock as to which Mr. P. Cavazza has the sole power
to vote or direct the vote is zero. The number of shares of Common
Stock as to which Mr. P. Cavazza shares the power to vote or direct the vote
is
14,255,553. The number of shares of Common Stock as to which Mr. P.
Cavazza has the sole power to dispose or direct the disposition is
zero. The number of shares
| CUSIP No. 232808105 |
13D
|
Page 12
of 22
Pages
|
of
Common Stock as to which Mr. P. Cavazza shares the power to dispose or direct
the disposition is 7,797,327.
Sigma
Tau International
The
number of shares of Common Stock as to which Sigma Tau International has the
sole power to vote or direct the vote is zero. The number of shares
of Common Stock as to which Sigma Tau International shares the power to vote
or
direct the vote is 14,255,553. The number of shares of Common Stock
as to which Sigma Tau International has the sole power to dispose or direct
the
disposition is zero. The number of shares of Common Stock as to which
Sigma Tau International shares the power to dispose or direct the disposition
is
zero.
Sigma
Tau
The
number of shares of Common Stock as to which Sigma Tau has the sole power to
vote or direct the vote is zero. The number of shares of Common Stock
as to which Sigma Tau shares the power to vote or direct the vote is
14,255,553. The number of shares of Common Stock as to which Sigma
Tau has the sole power to dispose or direct the disposition is
zero. The number of shares of Common Stock as to which Sigma Tau
shares the power to dispose or direct the disposition is zero.
Defiante
The
number of shares of Common Stock as to which Defiante has the sole power to
vote
or direct the vote is zero. The number of shares of Common Stock as
to which Defiante shares the power to vote or direct the vote is
14,255,553. The number of shares of Common Stock as to which Defiante
has the sole power to dispose or direct the disposition is zero. The
number of shares of Common Stock as to which Defiante shares the power to
dispose or direct the disposition is zero.
Aptafin
The
number of shares of Common Stock as to which Aptafin has the sole power to
vote
or direct the vote is zero. The number of shares of Common Stock as
to which Aptafin shares the power to vote or direct the vote is
14,255,553. The number of shares of Common Stock as to which Aptafin
has the sole power to dispose or direct the disposition is zero. The
number of shares of Common Stock as to which Aptafin shares the power to dispose
or direct the disposition is 7,797,327.
Chaumiere
The
number of shares of Common Stock as to which Chaumiere has the sole power to
vote or direct the vote is zero. The number of shares of Common Stock
as to which Chaumiere shares the power to vote or direct the vote is
14,255,553. The number of shares of Common Stock as to which
Chaumiere has the sole power to dispose or direct the disposition is
zero. The number of shares of Common Stock as to which Chaumiere
shares the power to dispose or direct the disposition is 7,248,227.
Inverlochy
The
number of shares of Common Stock as to which Inverlochy has the sole power
to vote or direct the vote is zero. The number of shares of Common
Stock as to which Inverlochy shares the power to vote or direct the vote is
14,255,553. The number of shares of Common Stock as to
which Inverlochy has the sole power to dispose or direct the disposition is
zero. The number of shares of Common Stock as to
which Inverlochy shares the power to dispose or direct the disposition is
4,701,445.
(c) On
November 20, 2007, Chaumiere used its working capital to purchase 2,446,782
shares of Common Stock from Mr.P. Cavazza at a purchase price of $4.68 per
share.
| CUSIP No. 232808105 |
13D
|
Page 13
of 22
Pages
|
|
Item
7.
|
Material
to be Filed as Exhibits.
|
Item
7 of the Schedule 13Ds are hereby amended to add the following:
EXHIBIT
11– Joint Filing Agreement dated December 21, 2006 by and between the
Reporting Persons (incorporated by reference to Exhibit 7 to the Schedule
13Ds).
EXHIBIT
12 – Power of Attorney dated December 21, 2006 by Inverlochy
(incorporated by reference to Exhibit 8 to the Schedule 13Ds).
EXHIBIT
13 – Power of Attorney dated April 15, 2005 by Chaumiere –
Consultadoria & Servicos SDC Unipessoal LDA (incorporated by reference to
Exhibit 2 to the Schedule 13Ds).
EXHIBIT
14 – Power of Attorney dated April 8, 2003 by and between Claudio
Cavazza, Paolo Cavazza, Sigma-Tau International S.A., Sigma-Tau Finanziaria
SpA,
Defiante Farmaceutica L.D.A. and Aptafin S.p.A. (incorporated by reference
to
Exhibit 1 of Form 4, filed with the SEC on May 9, 2003, relating to the shares
of Common Stock)
| CUSIP No. 232808105 |
13D
|
Page 14
of 22
Pages
|
|
|
Signatures
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Claudio Cavazza
is
true, complete and correct.
Dated: November
21, 2007
|
CLAUDIO
CAVAZZA
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Claudio
Cavazza
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Paolo Cavazza is
true, complete and correct.
Dated: November
21, 2007
|
PAOLO
CAVAZZA
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for Paolo
|
|||
|
Cavazza
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Sigma-Tau
Finanziaria SpA is true, complete and correct.
Dated: November
21, 2007
|
SIGMA-TAU
FINANZIARIA SPA
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Sigma-Tau
Finanziari SpA
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Sigma-Tau
International S.A. is true, complete and correct.
Dated: November
21, 2007
|
SIGMA-TAU
INTERNATIONAL S.A.
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Sigma-Tau
International S.A.
|
|||
| CUSIP No. 232808105 |
13D
|
Page 15
of 22 Pages
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Defiante
Farmaceutica L.D.A. is true, complete and correct.
Dated: November
21, 2007
|
DEFIANTE
FARMACEUTICA L.D.A.
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Defiante
Farmaceutica L.D.A.
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Aptafin S.p.A.
is
true, complete and correct.
Dated: November
21, 2007
|
APTAFIN
S.P.A.
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Aptafin
S.p.A.
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Chaumiere -
Consultadoria & Servicos SDC Unipessoal LDA is true, complete and
correct.
Dated: November
21, 2007
|
CHAUMIERE
- CONSULTADORIA &
|
|||
|
SERVICOS
SDC UNIPESSOAL LDA
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Chaumiere
- Consultadoria & Servicos SDC
|
|||
|
Unipessoal
LDA
|
|||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement with respect to Inverlochy
Consultadoria & Servicos L.D.A. is true, complete and correct.
Dated: November
21, 2007
|
INVERLOCHY
CONSULTADORIA &
|
|||
|
SERVICOS
L.D.A.
|
|||
|
By:
|
/s/
Maurizio Terenzi
|
||
|
Maurizio
Terenzi, Attorney-in-fact for
|
|||
|
Inverlochy
Consultadoria & Servicos L.D.A.
|
|||
| CUSIP No. 232808105 |
13D
|
Page 16
of 22 Pages
|
The
original statement shall be signed by each person on whose behalf the statement
is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed
with
the statement, provided, however, that a power of attorney for
this purpose which is already on file with the Commission may be incorporated
by
reference. The name of any title of each person who signs the
statement shall be typed or printed beneath his signature.
Attention: Intentional
misstatements or omissions of fact constitute Federal criminal violations
(see 18 U.S.C. 1001).
| CUSIP No. 232808105 |
13D
|
Page 17
of 22
Pages
|
Schedule
A
EXECUTIVE
OFFICERS AND DIRECTORS
Sigma
Tau Finanziaria SpA
|
NAME
|
ADDRESS
|
TITLE
|
CITIZENSHIP
|
|
Claudio
Cavazza
|
via
Pontina Km. 30,400,
00040
Pomezia (Rome)
Italy
|
President
|
Italian
|
|
Ugo
Di Francesco
|
via
Sudafrica,20,
00144
Rome Italy-
|
Vice
President and Chief
Executive
Officer
|
Italian
|
|
Antonio
Nicolai
|
via
Sudafrica,20,
00144
Rome Italy
|
Managing
Director
|
Italian
|
|
Mauro
Bove
|
via
Sudafrica,20,
00144
Rome Italy
|
Managing
Director
|
Italian
|
|
Stefano
Marino
|
via
Pontina Km. 30,400
00040
Pomezi (Rome) Italy
|
Managing
Director
|
Italian
|
|
Trevor
M. Jones CBA
|
Woodhyrst
House
18
Friths Drive
REIGATE
Surrey
Great
Britain
|
Director
|
British
|
|
Emilio
Plate
|
via
Pontina Km. 30,400
00040
Pomezi (Rome) Italy
|
Director
|
Italian
|
|
Mario
Artali
|
via
Sudafrica,20,
00144
Rome Italy
|
Director
|
Italian
|
|
Enrico
Cavazza
|
via
Pontina Km. 30,400
00040
Pomezi (Rome) Italy
|
Director
|
Italian
|
|
Marco
Cerrina Feroni
|
Piazza
Paolo Ferrari 10
20121
Milano, Italy
|
Director
|
Italian
|
| CUSIP No. 232808105 |
13D
|
Page 18
of 22
Pages
|
Schedule
A
EXECUTIVE
OFFICERS AND DIRECTORS
Sigma-Tau
International S.A.
|
NAME
|
ADDRESS
|
TITLE
|
CITIZENSHIP
|
|
Ugo
Di Francesco
|
via
Sudafrica,20,
00144
Rome Italy-
|
President
|
Italian
|
|
Jonathan
Lepage
|
Bd.
Du Prince Henri 19-21
L-1724
Luxembourg
|
Director
|
Belgian
|
|
Luca
Checchinato
|
Bd.
Du Prince Henri 19-21
L-1724
Luxembourg
|
Director
|
Italian
|
|
Antonio
Nicolai
|
via
Sudafrica,20,
00144
Rome Italy
|
Director
|
Italian
|
|
Mauro
Bove
|
via
Sudafrica,20,
00144Rome
Italy
|
Director
|
Italian
|
|
Gustave
Stoffel
|
18
Avenue De La Porte Neuve
L-2227
Luxembourg
|
Director
|
Luxembourg
|
|
Dominique
Audia
|
Bd.
Du Prince Henri 19-21
L-1724
Luxembourg
|
Director
|
French
|
| CUSIP No. 232808105 |
13D
|
Page 19
of 22 Pages
|
Schedule
A
EXECUTIVE
OFFICERS AND DIRECTORS
Defiante
Farmaceutica L.D.A.
|
NAME
|
ADDRESS
|
TITLE
|
CITIZENSHIP
|
|
Antonio
Nicolai
|
via
Sudafrica,20,
00144
Rome Italy
|
Director
|
Italian
|
|
Raffaele
Sanguigni
|
Via
Pontina Km. 30.400 – 00040 Pomezia
(Rome)
Italy
|
Director
|
Italian
|
|
Paulo
Alexandre da Mota Viegas
|
Rua
dos Tanoeiros, 12º - 2º e 3º - Funchal -
Madeira
- Portugal 9000
|
Director
|
Portuguese
|
|
Pedro
Moreira da Cruz Quintas
|
Rua
dos Ferreiros, 260 - Funchal - Madeira -
Portugal
9000-082
|
Director
|
Portuguese
|
|
Carla
Emanuel Arruda Jardim
Fernandes
|
Rua
dos Ferreiros, 260 - Funchal - Madeira -
Portugal
9000-082
|
Director
|
Portuguese
|
| CUSIP No. 232808105 |
13D
|
Page 20
of 22
Pages
|
Schedule
A
EXECUTIVE
OFFICERS AND DIRECTORS
Aptafin
S.p.A.
|
NAME
|
ADDRESS
|
TITLE
|
CITIZENSHIP
|
|
Cristina
Cavazza
|
Viale
Shakespeare, 47
00144
Rome Italy
|
President
|
Italian
|
|
Maurizio
Terenzi
|
via
Sudafrica,20,
00144
Rome Italy-
|
Managing
Director
|
Italian
|
|
Antonio
Nicolai
|
via
Sudafrica,20,
00144
Rome Italy-
|
Director
|
Italian
|
|
Emanuela
Cavazza
|
Viale
Shakespeare 47
00144
Rome Italy-
|
Director
|
Italian
|
| CUSIP No. 232808105 |
13D
|
Page 21
of 22
Pages
|
Schedule
A
EXECUTIVE
OFFICERS AND DIRECTORS
Chaumiere
- Consultadoria & Servicos SDC Unipessoal LDA
|
NAME
|
ADDRESS
|
TITLE
|
CITIZENSHIP
|
|
Roberto
Carlos de
Castro
Abreu
|
Avenida
da República, 32, 4.º
Esquerdo,
1050-193 Lisboa,
Portugal
|
Director
|
Portuguese
|
|
João
Josè de Freitas
Rodrigues
|
Avenida
da República, 32, 4.º
Esquerdo,
1050-193 Lisboa,
Portugal
|
Director
|
Portuguese
|